| View |
|
DRP-6763-02
|
Rabeprazole sodium
|
Rabprez
|
20 mg
|
Powder for Solution for Intravenous Injection
|
Proton Pump Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
-
|
09 March 2022
|
20 July 2026
|
| View |
|
DRP-8991-01
|
Pantoprazole (as sodium sesquihydrate)
|
I-Panto
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals and Pharmaceuticals)
|
India
|
-
|
09 March 2022
|
29 July 2025
|
| View |
|
DRP-9638-02
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
TAZASTAR-2.25
|
2 g/250 mg
|
Powder for IV Infusion
|
-
|
Injectcare Parenterals Pvt. Ltd.
|
India
|
-
|
09 March 2022
|
23 April 2026
|
| View |
|
DRP-7097-03
|
Ursodeoxycholic Acid
|
Rexibile
|
300 mg
|
Film-Coated Tablet
|
Bile Salt
|
Scott-Edil Pharmacia Limited
|
India
|
-
|
09 March 2022
|
14 March 2027
|
| View |
|
DRP-11381
|
Pregabalin
|
Grabalin
|
75 mg
|
Capsule
|
-
|
Gracure Pharmaceutical Ltd.
|
India
|
-
|
08 March 2022
|
24 July 2025
|
| View |
|
DRP-11382
|
Cefoxitin (as sodium)
|
Acifox
|
1 g
|
Powder for Solution for Injection (I.M./I.V.)
|
-
|
NCPC Hebei Huamin Pharmaceutical Co., Ltd.
|
China
|
-
|
08 March 2022
|
25 November 2025
|
| View |
|
DRP-11373
|
Celecoxib
|
Lecox-200
|
200 mg
|
Capsule
|
-
|
Gracure Pharmaceutical Ltd.
|
India
|
-
|
08 March 2022
|
23 November 2026
|
| View |
|
BRP-037-04
|
Insulin Glargine
|
Ylateq
|
100 IU/mL
|
Solution for Injection (SC)
|
Long-acting Insulin
|
Wockhardt Limited
|
India
|
Renewal
|
16 November 2023
|
03 March 2029
|
| View |
|
DRP-10512-07
|
Febuxostat
|
Q-Tem
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Stallion Laboratories Pvt. Ltd.
|
India
|
-
|
07 March 2022
|
07 October 2026
|
| View |
|
DRP-4381-05
|
Cefixime (as trihydrate)
|
Ximetaz
|
100 mg/5 mL
|
Powder for Suspension
|
Antibacterials
|
Akums Drugs & Pharmaceuticals Ltd. (Plant I - Solid Oral Dosage Facility)
|
India
|
Renewal
|
22 March 2023
|
18 April 2028
|
| View |
DRP-6840-03_PI_01.pdf
|
DRP-6840-03
|
Montelukast (as sodium)
|
Leukast
|
5 mg
|
Chewable Tablet
|
Leukotriene Receptor Antagonist
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
03 March 2022
|
30 June 2025
|
| View |
|
DRP-8704-01
|
Sevoflurane
|
Veeforane
|
100% Liquid for Inhalation
|
|
General Anesthetic
|
Shanghai Hengrui Pharmaceutical Co., Ltd.
|
China
|
-
|
03 March 2022
|
07 February 2025
|
| View |
|
DRP-11295-01
|
Ambroxol Hydrochloride
|
None
|
30 mg
|
Tablet
|
Mucolytic
|
Centurion Laboratories Pvt. Ltd.
|
India
|
-
|
03 March 2022
|
24 November 2026
|
| View |
|
DRP-11296-01
|
Carbocisteine
|
None
|
500 mg
|
Capsule
|
Mucolytic
|
Centurion Laboratories Pvt. Ltd
|
India
|
-
|
03 March 2022
|
26 November 2026
|
| View |
|
DRP-10877-01
|
Sevelamer Carbonate
|
K-Guard 800
|
800 mg
|
Film-Coated Tablet
|
Phosphate Binder
|
Globela Pharma Private Limited
|
India
|
-
|
03 March 2022
|
10 December 2026
|
| View |
|
DRP-11229-01
|
Moxifloxacin (as Hydrochloride)
|
MoxiDen
|
5mg/mL (0.5% w/v)
|
Ophthalmic Solution
|
Anti-infectives (Fluoroquinolones)
|
Makcur Laboratories Ltd
|
India
|
-
|
25 May 2022
|
01 April 2027
|
| View |
|
DRP-11312
|
BORTEZOMIB
|
FONKOZOMIB
|
3.5 mg
|
Lyophilized Powder for Injection (IV)
|
ANTINEOPLASTIC AGENT
|
PT Fonko International Pharmaceuticals
|
Indonesia
|
Renewal
|
21 March 2024
|
16 September 2029
|
| View |
|
DRP-3719
|
Trimetazidine Hydrochloride
|
TMZ-MR
|
35 mg
|
Modified-Release Tablet
|
Anti-Angina (Fatty Acid Oxidation [pFOX] Inhibitor)
|
Sydler Remedies Pvt. Limited
|
India
|
-
|
21 March 2022
|
17 April 2027
|
| View |
|
DR-XY27826
|
Furosemide
|
None
|
10mg/mL
|
Solution for Injection
|
Diuretic
|
Atlantic Laboratories Corporation Limited
|
Thailand
|
-
|
21 March 2022
|
20 September 2027
|
| View |
|
DR-XY27931
|
Chlorphenamine Maleate
|
None
|
10mg/mL
|
Solution for Injection (IM/IV/SC)
|
Antihistamine
|
Atlantic Laboratories Corporation Limited
|
Thailand
|
-
|
21 March 2022
|
11 October 2027
|